Phase IIa, Randomized, Double Blinded, Placebo Controlled, Dose Finding Study for TLC599 in OA Patients

NCT03005873 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis of the Knee

Interventions

DRUG: TLC599 LD group
DRUG: Normal Saline
DRUG: TLC599 HD group

Sponsor

Taiwan Liposome Company